Author:
Ray Rinki,Prettyman Richard
Abstract
The use of anti-dementia medication is expected to rise with increasing demand and a growing elderly population. With the implementation of the “Living well with Dementia: National Dementia Strategy” document in the United Kingdom, there is an increased awareness along with an urge for early diagnosis and initiation of treatment.
Publisher
Cambridge University Press (CUP)
Subject
Psychiatry and Mental health,Geriatrics and Gerontology,Gerontology,Clinical Psychology
Reference2 articles.
1. National Institute for Clinical Excellence (NICE) (2010). Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer's Disease. Review of NICE Technology Appraisal Guidance 217. London: NICE.
2. Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献